Cellular mechanisms in selected states of insulin resistance: Human obesity, glucocorticoid excess, and chronic renal failure

Diabetes/Metabolism Reviews

Volumn 1, Issue 3, 1985, Pages 293-317

  Amatruda, John M ^a   Livingston, James N ^a   Lockwood, Dean H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; INSULIN; INSULIN I 125; INSULIN RECEPTOR; PREDNISONE;

BLOOD AND HEMOPOIETIC SYSTEM; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DRUG BINDING; DRUG INTERACTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG THERAPY; ENDOCRINE SYSTEM; HUMAN; INSULIN RESISTANCE; KIDNEY; KIDNEY FAILURE; OBESITY; PHARMACOKINETICS; PROTEIN SYNTHESIS; REVIEW; SOFT TISSUE; SUBCUTANEOUS DRUG ADMINISTRATION; THERAPY;

ANIMAL; GLUCOCORTICOIDS; GLUCOSE; HUMAN; INSULIN RESISTANCE; LIPIDS; LIVER; LIVER GLYCOGEN; OBESITY; PEPTIDES; RECEPTOR, INSULIN; SUPPORT, U.S. GOV'T, P.H.S.; UREMIA;

EID: 0022250141     PISSN: 07424221     EISSN: 10990895     Source Type: Journal    
DOI: 10.1002/dmr.5610010304     Document Type: Article

References (100)

1. Insulin receptor interaction in the obese hyperglycemic mouse: a model of insulin resistance
2. Insulin insensitivity of large fat cells
3. Insulin receptor interaction in human obesity
4. Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects
5. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects
6. Relationship between in vivo insulin resistance and decreased insulin receptors in obese men
7. Mechanisms of insulin resistance in human obesity
8. Mechanism of the postreceptor defect in insulin action in human obesity
9. Insulin receptor binding and insulin action in human fat cells: effects of obesity and fasting
10. Insulin binding and responsiveness in fat cells from patients with reduced glucose tolerance and type II diabetes
11. Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity
12. In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose tolerance
13. Defect in insulin binding to receptors in obese man: amelioration with caloric restriction
14. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding and dieting
15. Insulin receptors on monocytes and erythrocytes from obese patients
16. The relation between glucose tolerance and insulin binding to circulating monocytes in obese children
17. Insulin receptors in obesity–a reassessment
18. Insulin binding to monocytes in obese patients treated with carbohydrate restriction and changes in physical activity
19. The insulin receptor of human monocyte‐like cell line: characterization and function
20. Rapid effects of insulin on the cycling of the insulin receptor in a human monocyte cell line (U‐937)
21. The relationship between the insulin‐binding capacity of fat cells and the cellular response to insulin: studies with intact and trypsin‐treated fat cells
22. Insulin resistance, insulin insensitivity and insulin unresponsiveness: a necessary distinction
23. Studies of liver insulin receptors in non‐obese and obese human subjects
24. The influence of obesity and diabetes in the monkey on insulin and glucagon binding to liver membranes
25. Splanchnic glucose and amino acid metabolism in obesity
26. The glucagon receptor of human liver: studies of its molecular weight and binding properties, and ability to activate adenylyl cyclase of non‐obese and obese subjects
27. Erythrocyte and monocyte insulin binding in man
28. Interaction of cross‐linking agents with the insulin effector system of isolated fat cells
29. Insulin resistance and insulin action. A in vitro and in vivo perspective
30. Time course of insulin binding and insulininduced lipogenesis in isolated rat fat cells
31. The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia and starvation
32. Marked increase in insulin sensitivity of human cells one hour after glucose ingestion
33. Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion
34. Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms and physiological significance
35. Influence of adrenal cortical steroids on carbohydrate metabolism
36. Effect of glucocorticoids on plasma insulin
37. Hyperglucogonism induced by glucocorticoid treatment in man
38. An in vivo and in vitro study of the mechanism of prednisone‐induced insulin resistance in healthy subjects
39. Cortisol‐induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action
40. Insulin resistance in Cushing's syndrome
41. Insulin induced alterations in insulin binding and insulin action in primary cultures of rat hepatocytes
42. The sugar transport system in striated muscle: effect of growth hormone, hydrocortisone and alloxan diabetes
43. Response of epididymal adipose tissue to small concentrations of insulin: effect of cortisone
44. Antogonism of insulin action on glucose metabolism in white fat cells by dexamethasone
45. Effect of glucocorticoids on the glucose transport system of isolated fat cells
46. Effect of dexamethasone on insulin binding, glucose transport and glucose oxidation of isolated rat adipocytes
47. Influence of dexamethasone on insulin action: inhibition of basal and insulin‐stimulated hexose transport is dependent on length of exposure in vitro
48. Glucocorticoids decrease the number of glucose transporters in the plasma membranes of isolated rat adipocytes. Abstract
49. Glucocorticoid hormone action
50. Glucocorticoid induced insulin resistance: the importance of post‐binding events in the regulation of insulin binding, action, and degradation in primary cultures of rat hepatocytes
51. The effects of glucocorticoids on insulin stimulated lipogenesis in primary cultures of rat hepatocytes
52. Glucocoticoids increase synthesis of the insulin receptor
53. The effects of methyl‐prednisolone and diabetes on the turnover of alanine and on the transfer of carbon atoms from alanine to pyruvate and glucose in dogs
54. The stimulation of mitochondrial pyruvate carboxylation after dexamethasone treatment of rats
55. Hormonal regulation of amino acid transport and gluconeogenesis in primary cultures of adult rat liver parenchymal cells
56. The effect of chronic sulfonylurea therapy on hepatic glucose production in non‐insulin‐dependent diabetes
57. The glucose paradox: is glucose a substrate for liver metabolism?
58. The role of insulin and glucocorticoids in the regulation of hepatic glycogen metabolism: effect of fasting, refeeding, and adrenalectomy
59. Effects of dexamethasone administration on hepatic glycogen synthesis and accumulation in adrenalectomized fasted rats
60. Induction of hepatic glycogen synthesis by glucocorticoids is not mediated by insulin
61. Effect of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes
62. Carbohydrate metabolism in uremia. A review
63. Carbohydrate metabolism in uremia
64. Effect of chronic renal failure and hemodialysis on carbohydrate metabolism
65. Abnormal carbohydrate metabolism in uremia
66. Glucose intolerance in uremia
67. The site of insulin resistance in acute uremia
68. Cellular basis of insulin resistance in chronic uremia
69. Insulin resistance in uremia
70. Insulin resistance in uremia: characterization of lipid metabolism in freshly isolated and primary cultures of hepatocytes from chronic uremic rats
71. Erythrocyte insulin receptors in chronic renal failure
72. Effect of prolonged uremia on insulin metabolism by isolated liver and muscle
73. Insulin resistance in uremia mediated by postbinding defects
74. Insulin, glucagon and thyroid hormone
75. Insulin resistance in uremia: characterization of insulin action, binding, and processing in isolated hepatocytes from chronic uremic rats
76. Induction of insulin resistance in normal adipose tissue by uremic human serum
77. Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism
78. Study of the effect of uremic metabolites on erythrocyte glycolysis
79. Metabolic alterations caused by uremia
80. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance
81. Insulin resistance in uremia is due to a post insulin receptor kinase defect(s)
82. Uremic middle molecules exist and are biologically active
83. Insulin stimulates the phosphorylation of the 95,000 dalton subunit of its own receptor
84. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell‐free system
85. Insulin receptor evidence that it is a protein kinase
86. The β subunit of the insulin receptor is an insulin‐activated protein kinase
87. Characteristics of insulin and epidermal growth factor stimulation of receptor autophosphorylation in detergent extracts of rat liver and transplantable rat hepatomas
88. Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation
89. Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin‐generated mediator from muscle
90. Production by plasma membranes of a chemical mediator of insulin action
91. Insulin resistance in the liver in fasting and diabetic mellitus: the failure of insulin to stimulate the release of chemical modulator of pyruvate dehydrogenase
92. Effect of high fat and high carbohydrate diets on adipose tissue pyruvate dehydrogenase and its activation by a plasma membrane‐enriched fraction and insulin
93. Effect of dexamethasone on adipose tissue and liver pyruvate dehydrogenase and its stimulation by insulin‐generated chemical mediator
94. Insulin resistance in uremia: in vitro model to study mechanism(s) in the liver. Abstract
95. Regulation of insulin receptor metabolism
96. Insulin‐stimulated translocation of glucose transport systems in the isolated rat adipose cell
97. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from intracellular storage site
98. Molecular basis of insulin action
99. Insulin secretion and action